Cancer feature: cnaPANCAN164

ABCC9 AEBP2 AMN1 ARNTL2 ASUN BCAT1 BHLHE41 BICD1 C12orf39 C12orf71 C12orf77 C2CD5 CAPRIN2 CAPZA3 CASC1 CCDC91 CMAS DDX11 DENND5B DNM1L ERGIC2 ETNK1 FAM60A FAR2 FGD4 FGFR1OP2 GOLT1B GYS2 H3F3C IAPP IFLTD1 IPO8 ITPR2 KCNJ8 KIAA1551 KLHL42 KRAS LDHB LRMP LST3 LYRM5 MANSC4 MED21 METTL20 MRPS35 OVCH1 OVCH1-AS1 PDE3A PIK3C2G PKP2 PLCZ1 PLEKHA5 PPFIBP1 PTHLH PYROXD1 RASSF8 RECQL REP15 RERGL RP11-125O5.2 SLCO1A2 SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1 SMCO2 SOX5 SSPN ST8SIA1 STK38L TM7SF3 TMTC1 TSPAN11 YARS2

Known Driver Genes: KRAS

Copy number alternation: gain

Eg5_9814

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer